Organization Overview
Alternative names
allogeneic stem cells (5 trials)
asparaginase (elspar) (9 trials)
autologous hematopoietic cell (1 trial)
busulfan (myleran) (12 trials)
carboplatin (paraplatin) (13 trials)
cisplatin (platinol) (11 trials)
cladribine (leustatin) (1 trial)
clofarabine (clolar) (11 trials)
cyclophosphamide (cytoxan) (60 trials)
cytarabine (cytosar-u) (31 trials)
dasatinib (sprycel) (5 trials)
erwinia asparaginase (Erwinaze) (8 trials)
etoposide (vepesid) (43 trials)
fludarabine (fludara) (29 trials)
gemtuzumab ozogamicin (mylotarg) (1 trial)
hemopoietic stem cell (4 trials)
hydroxyurea (hydrea) (10 trials)
idarubicin (idamycin) (3 trials)
melphalan (alkeran) (20 trials)
mercaptopurine (purinethol) (14 trials)
mitoxantrone (novantrone) (8 trials)
muromonab cd3 (Orthoclone OKT3) (7 trials)
naltrexone (revia) (27 trials)
pegaspargase (oncaspar) (9 trials)
pentostatin (nipent) (1 trial)
prednisone (meticorten) (16 trials)
prilocaine (citanest) (1 trial)
procaine benzylpenicillin (novocaine) (1 trial)
acetaminophen (tylenol) (1 trial)
aldesleukin (proleukin) (8 trials)
alemtuzumab (campath) (4 trials)
allogeneic hematopoietic stem cells (Hemacord) (6 trials)
allogeneic lymphocytes (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (7 trials)
autologous bone marrow (1 trial)
azacitidine (vidaza) (1 trial)
azathioprine (imuran) (1 trial)
bendamustine (treanda) (3 trials)
bevacizumab (avastin) (5 trials)
bleomycin (blenoxane) (4 trials)
blinatumomab (blincyto) (2 trials)
bortezomib (velcade) (4 trials)
brentuximab vedotin (adcetris) (2 trials)
cd45-depleted allogenic peripheral blood stem cell (3 trials)
cl20-4i-ef/a-hyc-opt (1 trial)
dacarbazine (dtic-dome) (2 trials)
dactinomycin (cosmegen) (1 trial)
decitabine (dacogen) (1 trial)
dexrazoxane (zinecard) (2 trials)
dinutuximab (unituxin) (3 trials)
diphenhydramine (benadryl) (1 trial)
dolutegravir (tivicay) (1 trial)
erlotinib (tarceva) (2 trials)
filgrastim (neupogen) (10 trials)
fludeoxyglucose f-18 (2 trials)
fluorouracil (efudex) (2 trials)
gabapentin (neurontin) (2 trials)
gemcitabine (gemzar) (3 trials)
haplo-identical hematopoietic stem cells (1 trial)
haploidentical transplantation of t-cell depleted graft (1 trial)
hydrocortisone (solu-cortef) (2 trials)
interferon alpha-2b (Intron-A) (1 trial)
irinotecan (Camptosar) (11 trials)
isotretinoin (accutane) (2 trials)
lamivudine (epivir) (2 trials)
levetiracetam (keppra) (1 trial)
lisinopril (zestril) (1 trial)
mechlorethamine (mustargen) (3 trials)
metformin (glucophage) (1 trial)
methylprednisolone (medrol) (2 trials)
mycophenolate (myfortic) (6 trials)
nelarabine (arranon) (1 trial)
panobinostat (farydak) (2 trials)
peripheral blood hematopoietic cell (4 trials)
pidolic acid magnesium salt (2 trials)
plerixafor (mozobil) (4 trials)
ruxolitinib (jakafi) (2 trials)
sirolimus (rapamune) (3 trials)
sorafenib (nexavar) (6 trials)
tacrolimus (prograf) (3 trials)
talazoparib (talzenna) (2 trials)
tamoxifen (nolvadex) (1 trial)
t cell depleted hematopoietic stem cells (1 trial)
temozolomide (temodar) (5 trials)
temsirolimus (torisel) (2 trials)
vinblastine (velban) (8 trials)
vinorelbine (navelbine) (1 trial)
vismodegib (erivedge) (1 trial)
allogeneic neuroblastoma cells (1 trial)
autologous cd133+ stem cells (1 trial)
autologous mesenchymal stem cells (1 trial)
autologous natural killer cells (1 trial)
crizotinib (xalkori) (1 trial)
cyclosporine (sandimmune) (2 trials)
emtricitabine (emtriva) (1 trial)
everolimus (zortress) (2 trials)
fluorodopa (fluorodopa F18) (1 trial)
Abdominal Neoplasms (Phase 1)
Acquired Immunodeficiency Syndrome (Phase 1)
Adamantinoma (Phase 2)
Adenocarcinoma, Clear Cell (Phase 1)
Adenomyoepithelioma (Phase 1)
Anemia (Phase 3)
Anemia, Aplastic (Phase 2)
Anemia, Sickle Cell (Phase 3)
Astrocytoma (Phase 1)
Bone Marrow Diseases (Phase 3)
Bone Neoplasms (Phase 3)
Brain Neoplasms (Phase 4)
Breast Neoplasms (Phase 2)
Burkitt Lymphoma (Phase 2)
Carcinoma (Phase 2)
Central Nervous System Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 3)
Craniopharyngioma (Phase 2)
Desmoplastic Small Round Cell Tumor (Phase 2)
Diarrhea (Phase 1)
Digestive System Neoplasms (Phase 1)
Dyskeratosis Congenita (Phase 2)
Ependymoma (Phase 2)
Fatigue (Phase 3)
Fibromatosis, Aggressive (Phase 2)
Ganglioglioma (Phase 1)
Ganglioneuroblastoma (Phase 1)
Gastrointestinal Neoplasms (Phase 1)
Glioblastoma (Phase 1)
Glioma (Phase 2)
Graft vs Host Disease (Phase 3)
Hematologic Diseases (Phase 3)
Hematologic Neoplasms (Phase 2)
Hemochromatosis (Phase 3)
Hemoglobinopathies (Phase 3)
Hemoglobin SC Disease (Phase 2)
Hemoglobinuria (Phase 3)
Hemoglobinuria, Paroxysmal (Phase 3)
Hemophilia A (Phase 1)
Hemophilia B (Phase 1)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 4)
Histiocytoma (Phase 2)
Histiocytoma, Benign Fibrous (Phase 2)
Histiocytoma, Malignant Fibrous (Phase 2)
Histiocytosis (Phase 2)
HIV Infections (Phase 2)
Hodgkin Disease (Phase 3)
Hypertension (Phase 2)
Immunoblastic Lymphadenopathy (Phase 1)
Immunologic Deficiency Syndromes (Phase 2)
Infections (Phase 3)
Influenza, Human (Phase 2)
Intraocular Lymphoma (Phase 1)
Leukemia (Phase 3)
Leukemia, B-Cell (Phase 2)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Hairy Cell (Phase 1)
Leukemia, Large Granular Lymphocytic (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Lymphoid (Phase 4)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myelomonocytic, Juvenile (Phase 3)
Leukemia, T-Cell (Phase 2)
Liver Neoplasms (Phase 2)
Lymphohistiocytosis, Hemophagocytic (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Extranodal NK-T-Cell (Phase 1)
Lymphoma, Large B-Cell, Diffuse (Phase 1)
Lymphoma, Large-Cell, Anaplastic (Phase 1)
Lymphoma, Large-Cell, Immunoblastic (Phase 1)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 1)
Lymphoma, T-Cell, Cutaneous (Phase 1)
Lymphoma, T-Cell, Peripheral (Phase 1)
Lymphomatoid Granulomatosis (Phase 1)
Malaria (Phase 1)
Medulloblastoma (Phase 3)
Melanoma (Phase 2)
Meningioma (Phase 1)
Mucositis (Phase 1)
Mycoses (Phase 1)
Mycosis Fungoides (Phase 1)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 1)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 2)
Neoplasms, Neuroepithelial (Phase 1)
Neoplasms, Unknown Primary (Phase 2)
Nervous System Neoplasms (Phase 3)
Neuralgia (Phase 2)
Neuroblastoma (Phase 2)
Neuroectodermal Tumors (Phase 3)
Neuroectodermal Tumors, Primitive (Phase 3)
Oligodendroglioma (Phase 1)
Osteochondrodysplasias (Phase 1)
Osteogenesis Imperfecta (Phase 1)
Osteonecrosis (Phase 2)
Osteoporosis (Phase 3)
Osteosarcoma (Phase 2)
Pancreatitis (Phase 2)
Pancytopenia (Phase 2)
Paramyxoviridae Infections (Phase 1)
Pelvic Neoplasms (Phase 1)
Pheochromocytoma (Phase 1)
Pinealoma (Phase 1)
Plasmablastic Lymphoma (Phase 1)
Pneumonia (Phase 3)
Preleukemia (Phase 3)
Purpura (Phase 2)
Purpura, Thrombocytopenic (Phase 2)
Purpura, Thrombocytopenic, Idiopathic (Phase 2)
Retinal Neoplasms (Phase 3)
Retinoblastoma (Phase 3)
Rhabdoid Tumor (Phase 3)
Rhabdomyosarcoma (Phase 2)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Sarcoma, Myeloid (Phase 2)
Severe Combined Immunodeficiency (Phase 2)
Sezary Syndrome (Phase 1)
Stomatitis (Phase 1)
Stroke (Phase 3)
Syndrome (Phase 1)
Teratoma (Phase 2)
Thalassemia (Phase 2)
Virus Diseases (Phase 1)
Wilms Tumor (Phase 2)
Wiskott-Aldrich Syndrome (Phase 1)
